Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial Cancer

NCT07731607 is registered in ClinicalTrials.gov with Wang Jianliu as lead sponsor.

NCT NCT07731607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07731607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial Cancer
Lead sponsor
Wang Jianliu
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 20, 2026
Completion date
July 20, 2030
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mmrd endometrial cancer of stage i~ii